Adjuvant therapy for pathologic stage C prostate cancer: A casualty of the PSA revolution?

M. S. Anscher

Research output: Contribution to journalEditorialpeer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Adjuvant therapy for pathologic stage C prostate cancer: A casualty of the PSA revolution?'. Together they form a unique fingerprint.